Diclofenac sodium
This medicine should always be used exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
Olfen hydrogel is a gel for topical application to the skin. The active substance of the medicine, diclofenac, belongs to a group of medicines known as nonsteroidal anti-inflammatory drugs (NSAIDs). Due to its water-alcohol base, Olfen hydrogel also has a soothing and cooling effect.
The medicine has analgesic, anti-inflammatory, and anti-edema effects.
It is used for local treatment of:
any of the other ingredients of this medicine (listed in section 6). In case of doubt, consult a doctor or pharmacist. Symptoms of hypersensitivity to the medicine may include: wheezing or shortness of breath (asthma), skin rash with blisters or hives, swelling of the face or tongue, rhinitis (hay fever),
If any of the above statements apply to the patient, they should not use Olfen hydrogel.
Before starting to use Olfen hydrogel, the patient should discuss it with their doctor or pharmacist.
In case of any doubts, the patient should consult a doctor or pharmacist before using Olfen hydrogel.
Since there is insufficient data on the efficacy and safety of using Olfen hydrogel in children and adolescents under 14 years of age, the medicine should not be used in this age group.
In adolescents over 14 years of age, if the medicine needs to be used for more than 7 days to treat pain or if the symptoms worsen, the patient should consult a doctor.
The patient should inform their doctor or pharmacist about all prescription or non-prescription medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult a doctor or pharmacist before using this medicine.
Olfen hydrogel should not be used during the last three months of pregnancy, as it may harm the unborn child or cause difficulties during delivery.
During the first six months of pregnancy, Olfen hydrogel should not be used unless it is necessary and recommended by a doctor. If use is necessary, the patient should use the smallest possible dose for the shortest possible time.
After oral administration (e.g., tablets), side effects may occur in the unborn child. It is not known if the same risk applies to Olfen hydrogel when used on the skin.
During breastfeeding, Olfen hydrogel may be used only on the advice of a doctor, as diclofenac passes into breast milk in small amounts. In such cases, the medicine should not be applied to the breast area of breastfeeding women or to large areas of skin or for extended periods.
Using Olfen hydrogel does not affect the ability to drive or operate machinery.
This medicine should always be used exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
In case of doubts, the patient should consult a doctor or pharmacist.
Olfen hydrogel should be applied topically to the skin three or four times a day. The amount of gel should be adjusted to the size of the affected area: 2 g to 4 g of Olfen hydrogel (an amount equivalent to the size of a cherry or a walnut) is sufficient.
When applying the gel, the patient may notice a slight cooling effect. Olfen hydrogel is for use on the skin only.
After application, the patient should wash their hands unless they are the area being treated.
After using the medicine, the patient should:
Do notuse the medicine for longer than:
Use the smallest possible dose for the shortest possible time.
If pain and swelling do not improve within 7 days or worsen, the patient should consult a doctor.
In case of using too much of the medicine, the excess should be removed with a tissue. If the gel is swallowed, the patient should contact a doctor immediately.
If a dose is missed, the patient should use the medicine as soon as they remember, and then continue with the recommended dosing schedule. The patient should not use a double dose to make up for the missed dose.
In case of any further doubts about using the medicine, the patient should consult a doctor or pharmacist.
Like all medicines, Olfen hydrogel can cause side effects, although not everybody gets them.
Other side effects that may occur when using Olfen hydrogel are usually mild and temporary. If the patient experiences any of the following symptoms, they should inform their doctor or pharmacist as soon as possible.
The risk of side effects is higher when using diclofenac on large areas of skin and for a long period.
If the patient experiences any side effects, including those not listed in this leaflet, they should inform their doctor, pharmacist, or nurse.
Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw
Tel: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, more information can be gathered on the safety of the medicine.
Side effects can also be reported to the marketing authorization holder.
The medicine should be kept out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after "Expiry date" or "EXP". The expiry date refers to the last day of the month stated.
The batch number on the packaging is stated after "Batch number" or "Lot".
Store in a temperature below 25°C.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer use. This will help protect the environment.
The active substance of the medicine is diclofenac sodium.
1 g of gel contains 10 mg of diclofenac sodium.
Other ingredients of the medicine are: isopropyl adipate, lactic acid, isopropyl alcohol, sodium metabisulfite, hydroxypropyl cellulose, hydroxyethyl cellulose, purified water.
Olfen hydrogel is a colorless to light yellow, transparent gel with a characteristic odor, in an aluminum tube in a cardboard box.
Available packaging:
50 g tube
100 g tube
Teva B.V.
Swensweg 5,
2031 GA Haarlem,
Netherlands
Merckle GmbH,
Ludwig-Merckle-Str. 3
89143 Blaubeuren
Germany
Teva Operations Poland Sp. z o.o.
ul. Mogilska 80,
31-546 Kraków
Teva Pharmaceuticals Polska Sp. z o.o.
tel. +48 22 345 93 00
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.